DrugBaron

JANUARY 31, 2024

Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). So what about the theoretical basis for the claim that AI can “revolutionise” drug discovery and development?

Pharma R&D 165

Pharma R&D Science Small Molecule Drugs 165

BenchSci

MARCH 6, 2024

While we have made tremendous progress in drug discovery over the last couple of decades, the process of discovering new drugs is time-consuming, intricate, and costly. Today, the pharmaceutical (pharma) industry is in the midst of a transformative era driven by the advent of Generative AI (GenAI).

Pharma R&D 52

Pharma R&D Clinical Trials Pharmaceuticals Trials 52

BenchSci

FEBRUARY 8, 2024

Earlier this month, I traveled across North America and the UK to meet our 340 team members. Every year in January, we kick off the year with our “Roadshow”, where I meet our team in person and share our accomplishments and learning from the previous year and where we are going next.

Pharma R&D 59

Pharma R&D Disease Drugs 59

The Pharma Data

JANUARY 10, 2021

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.

Pharma R&D 40

Pharma R&D Pharmaceuticals Pharmaceutical Companies Disease 40